Gallup puts US users near 38 million. Cornell data shows snack spending down 11% early on, while gyms and protein brands chase the new demand.
Recap by typeshit. Full story at kucoin.
The Illinois governor is speaking openly about his own GLP-1 use, saying he wants to end the stigma around the drugs. The post comes from a political fan page on Facebook.
Trell argues a toned lower body comes from lean muscle, crediting weekly strength training and recovery fuel rather than Ozempic or peptides.
The FDA cleared Awiqli as the first weekly insulin for kids 10 and up with type 2 diabetes, and a CagriSema subgroup showed 25% weight loss in women.
A rundown on the pill version of Wegovy, covering what form it comes in and its availability. Thin on details, so tap through for the specifics.
In over 61,000 matched patients, coded lymphedema hit 0.88% of GLP-1 users versus 2.58% of non-users. Authors call it hypothesis-generating, not proof.
Judge Zahid Quraishi found Novo failed to show irreparable harm, so Lilly's superiority ads stay up while the false advertising suit continues.
Loading…